Phase 2 Study to Assess Safety & Tolerability of a Single Injection Into the Knee Joint of Two Different Doses of MSB-CAR001 Combined With Hyaluronan Compared to Hyaluronan Alone in Patients Who Have Undergone an ACL Reconstruction
Phase of Trial: Phase I/II
Latest Information Update: 21 Dec 2016
At a glance
- Drugs Rexlemestrocel-L (Primary) ; Hyaluronic acid
- Indications Ligament injuries; Osteoarthritis
- Focus Adverse reactions
- Sponsors Mesoblast
- 15 Dec 2016 Status changed from active, no longer recruiting to completed.
- 01 Apr 2016 Results published in a Mesoblast media release.
- 01 Apr 2016 Results from IIa portion of the trial were presented at the 2016 Osteoarthritis Research Society International (OARSI) World Congress, according to a Mesoblast media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History